Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma: Results from a German real‐world cohortFabian Jost‐Brinkmann, Raphael Mohr, Münevver Demir et al.|Alimentary Pharmacology & Therapeutics|2023Cited by 57
Lessons From Immune Checkpoint Inhibitor Trials in Hepatocellular CarcinomaRaphael Mohr, Christoph Roderburg, Fabian Jost‐Brinkmann et al.|Frontiers in Immunology|2021Cited by 33
From Liver Cirrhosis to Cancer: The Role of Micro-RNAs in HepatocarcinogenesisRaphael Mohr, Christoph Roderburg, Burcin Özdirik et al.|International Journal of Molecular Sciences|2021Cited by 32
Association of Serum Calprotectin Concentrations with Mortality in Critically Ill and Septic PatientsTheresa H. Wirtz, Alexander Koch, Lukas Buendgens et al.|Diagnostics|2020Cited by 29